Ursodeoxycholic acid (Daewoong Pharmaceutical)

熊去氧胆酸 (大熊制药株式会社)

Report date: 2025/08/19 09:47:01

Base Information

Drug NameUrsodeoxycholic acid (Daewoong Pharmaceutical)
Drug Alias NameUDCA (Daewoong Pharmaceutical)DWJ-1464DWJ1464DWC-202109
ClassificationSmall molecules > Steroids
Mechanisms of ActionImmunosuppressantsCholesterol inhibitorsApoptosis inhibitors +[4] 
TargetsCholesterolBile acid receptor FXR
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsLiver Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2024/02/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A